Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole Augmentation in Treatment-Resistant Late-Life Depression
NCT00892047Phase 4Completed
- Sponsor
- University of Pittsburgh
- Start
- Aug 2009
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of aripiprazole in major depressive disorder (MDD), sponsored by University of Pittsburgh. Started Aug 2009; status: completed.
02
Drugs
aripiprazole
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00892047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00892047.